Mail

UK markets close in 4 hours 50 minutes

FTSE 100
8,372.41
+2.08(+0.02%)
FTSE 250
20,720.10
+10.03(+0.05%)
AIM
804.21
+0.34(+0.04%)
GBP/EUR
1.1733
-0.0015(-0.13%)
GBP/USD
1.2728
+0.0008(+0.06%)
Bitcoin GBP
54,767.27
-325.21(-0.59%)

How to protect your finances during divorce

However you do it divorce will leave you poorer, and you will need to watch your finances carefully

Vertex Pharmaceuticals Incorporated (VX1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

411.50

+0.20

(+0.05%)

As of 08:08AM CEST. Market open.

Currency in EUR

Earnings estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
No. of analysts	18	18	22	22
Avg. Estimate	3.06	3.13	12.34	13.11
Low estimate	2.7	2.53	11.5	11.13
High estimate	3.29	3.49	12.85	15
Year ago EPS	2.64	2.51	10.32	12.34

Revenue estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
No. of analysts	18	18	24	24
Avg. Estimate	1.85B	1.91B	7.29B	8.06B
Low estimate	1.73B	1.69B	6.94B	7.44B
High estimate	1.9B	2.01B	7.51B	8.75B
Year ago sales	N/A	1.63B	6.21B	7.29B
Sales growth (year/est)	N/A	17.40%	17.50%	10.50%

Earnings history	30/09/2020	31/12/2020	31/03/2021	30/06/2021
Est. EPS	2.34	2.59	2.69	2.51
Actual EPS	2.64	2.51	2.98	3.11
Difference	0.3	-0.08	0.29	0.6
Surprise %	12.80%	-3.10%	10.80%	23.90%

EPS trend	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
Current estimate	3.06	3.13	12.34	13.11
7 days ago	3.06	3.13	12.34	13.11
30 days ago	3.06	3.13	12.29	13.05
60 days ago	2.67	2.71	11.2	12.38
90 days ago	2.65	2.71	11.02	12.44

EPS revisions	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	2	3
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	VX1.F	Industry	Sector(s)	S&P 500
Current qtr.	15.90%	N/A	N/A	N/A
Next qtr.	24.70%	N/A	N/A	N/A
Current year	19.60%	N/A	N/A	N/A
Next year	6.20%	N/A	N/A	N/A
Next 5 years (per annum)	9.80%	N/A	N/A	N/A
Past 5 years (per annum)	95.80%	N/A	N/A	N/A